Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer.
Cell free biomarkers
Liquid biopsy-based diagnostics
Non-invasive biomarkers
Pancreatic cancer biomarkers
Proteomic biomarkers
Journal
World journal of gastroenterology
ISSN: 2219-2840
Titre abrégé: World J Gastroenterol
Pays: United States
ID NLM: 100883448
Informations de publication
Date de publication:
21 Apr 2023
21 Apr 2023
Historique:
received:
28
11
2022
revised:
02
02
2023
accepted:
15
03
2023
medline:
2
5
2023
pubmed:
1
5
2023
entrez:
1
5
2023
Statut:
ppublish
Résumé
A global increase in the incidence of pancreatic cancer (PanCa) presents a major concern and health burden. The traditional tissue-based diagnostic techniques provided a major way forward for molecular diagnostics; however, they face limitations based on diagnosis-associated difficulties and concerns surrounding tissue availability in the clinical setting. Late disease development with asymptomatic behavior is a drawback in the case of existing diagnostic procedures. The capability of cell free markers in discriminating PanCa from autoimmune pancreatitis and chronic pancreatitis along with other precancerous lesions can be a boon to clinicians. Early-stage diagnosis of PanCa can be achieved only if these biomarkers specifically discriminate the non-carcinogenic disease stage from malignancy with respect to tumor stages. In this review, we comprehensively described the non-invasive disease detection approaches and why these approaches are gaining popularity for their early-stage diagnostic capability and associated clinical feasibility.
Identifiants
pubmed: 37124888
doi: 10.3748/wjg.v29.i15.2241
pmc: PMC10134423
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2241-2260Informations de copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: The authors declare no conflicts of interest.
Références
Clin Cancer Res. 2013 Dec 1;19(23):6544-6555
pubmed: 24088737
Nat Rev Clin Oncol. 2018 Sep;15(9):541-563
pubmed: 29784926
J Cancer. 2018 Oct 11;9(21):3991-3999
pubmed: 30410604
Gut. 2020 Mar;69(3):540-550
pubmed: 31562239
Am J Blood Res. 2020 Jun 15;10(3):26-45
pubmed: 32685257
Am J Cancer Res. 2014 Nov 19;4(6):663-73
pubmed: 25520858
Curr Genomics. 2018 Sep;19(6):444-463
pubmed: 30258276
Oncotarget. 2016 Nov 1;7(44):71773-71781
pubmed: 27708234
J Pers Med. 2019 Apr 26;9(2):
pubmed: 31035449
Int J Cancer. 2017 Dec 15;141(12):2489-2497
pubmed: 28857158
Epigenomics. 2014;6(5):503-14
pubmed: 25431943
Epigenomes. 2021 Apr 09;5(2):
pubmed: 34968295
Cancer. 1983 Jun 1;51(11):2116-20
pubmed: 6188527
Curr Issues Mol Biol. 2022 Jun 10;44(6):2695-2709
pubmed: 35735625
J Exp Clin Cancer Res. 2012 Apr 30;31:38
pubmed: 22546315
J Proteome Res. 2009 Apr;8(4):1647-56
pubmed: 19714807
Cancers (Basel). 2022 May 14;14(10):
pubmed: 35626033
Am J Cancer Res. 2015 Dec 15;6(1):91-6
pubmed: 27073726
Mol Med. 2020 Jun 17;26(1):59
pubmed: 32552660
Life Sci. 1996;59(25-26):2187-99
pubmed: 8950323
J Natl Cancer Inst. 2019 Apr 1;111(4):372-379
pubmed: 30137376
Trends Cancer. 2020 May;6(5):392-406
pubmed: 32348735
Cancer Res. 2006 Jan 15;66(2):1208-17
pubmed: 16424060
Clin Cancer Res. 2015 Oct 1;21(19):4473-81
pubmed: 26023084
Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10202-10207
pubmed: 28874546
J Pathol Transl Med. 2020 May;54(3):204-212
pubmed: 32460474
Clin Epigenetics. 2020 Jul 23;12(1):112
pubmed: 32703318
Nat Rev Clin Oncol. 2022 Sep;19(9):600-612
pubmed: 35915225
Biochim Biophys Acta Rev Cancer. 2021 Apr;1875(2):188514
pubmed: 33497709
J Gastrointest Surg. 2014 Jan;18(1):7-15
pubmed: 24002763
Mol Oncol. 2020 Jun;14(6):1252-1267
pubmed: 32243066
BMC Cancer. 2019 Dec 3;19(1):1175
pubmed: 31795960
J Surg Oncol. 2009 Feb 1;99(2):119-22
pubmed: 19065635
Mol Diagn Ther. 2020 Apr;24(2):125-132
pubmed: 31919754
Pancreas. 2020 Jan;49(1):e13-e14
pubmed: 31856100
Clin Epigenetics. 2015 Oct 07;7:106
pubmed: 26451166
Science. 2018 Feb 23;359(6378):926-930
pubmed: 29348365
Cancer Biol Ther. 2010 Jul 1;10(1):54-64
pubmed: 20495387
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5003-8
pubmed: 21383194
Semin Cancer Biol. 2018 Aug;51:149-159
pubmed: 28807546
Cancer Lett. 2016 Feb 28;371(2):354-65
pubmed: 26708505
Mol Diagn Ther. 2019 Feb;23(1):83-95
pubmed: 30523565
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Diagnostics (Basel). 2021 Apr 25;11(5):
pubmed: 33923064
Sci Rep. 2019 Aug 12;9(1):11610
pubmed: 31406261
Cancer Res. 1977 Mar;37(3):646-50
pubmed: 837366
Cancer Res. 2003 Jul 1;63(13):3735-42
pubmed: 12839967
Genome Biol. 2013;14(9):R104
pubmed: 24070194
PLoS One. 2016 Jul 05;11(7):e0158669
pubmed: 27380024
Genes (Basel). 2019 Dec 23;11(1):
pubmed: 31877923
Exp Ther Med. 2021 Nov;22(5):1273
pubmed: 34594410
Mol Cell. 2007 Jun 8;26(5):745-52
pubmed: 17540599
Kidney Int. 2004 Jan;65(1):323-32
pubmed: 14675066
Chin Med J (Engl). 2019 Jun 20;132(12):1504-1506
pubmed: 31205116
Clin Epigenetics. 2019 Sep 6;11(1):132
pubmed: 31492175
Clin Cancer Res. 2015 Aug 1;21(15):3512-21
pubmed: 26240291
Cancer Biol Ther. 2009 Feb;8(4):340-6
pubmed: 19106647
Ann N Y Acad Sci. 2006 Sep;1075:165-73
pubmed: 17108207
Hepatobiliary Pancreat Dis Int. 2020 Jun;19(3):205-217
pubmed: 32312637
Gut. 2013 Sep;62(9):1373-80
pubmed: 23749606
Biomolecules. 2020 Dec 15;10(12):
pubmed: 33334040
J Clin Microbiol. 2019 Mar 28;57(4):
pubmed: 30404942
World J Gastroenterol. 2015 Jul 28;21(28):8527-40
pubmed: 26229396
Biomark Cancer. 2016 Apr 26;8(Suppl 1):27-35
pubmed: 27147897
Am J Gastroenterol. 2017 Jan;112(1):172-183
pubmed: 27845339
Nat Rev Clin Oncol. 2014 Mar;11(3):129-44
pubmed: 24445517
Nat Cell Biol. 2009 Dec;11(12):1487-95
pubmed: 19935649
Ann Oncol. 2020 Jun;31(6):745-759
pubmed: 33506766
Pancreas. 2013 Mar;42(2):193-7
pubmed: 23407481
PLoS One. 2014 Jan 08;9(1):e83113
pubmed: 24416156
Theranostics. 2021 Jan 1;11(6):2755-2769
pubmed: 33456571
PLoS One. 2015 Jun 29;10(6):e0130996
pubmed: 26121640
EBioMedicine. 2022 Jan;75:103797
pubmed: 34973624
Clin Chem. 2002 Oct;48(10):1647-53
pubmed: 12324479
Sci Transl Med. 2020 Jan 1;12(524):
pubmed: 31894106
Biomed Res Int. 2021 Nov 08;2021:1056622
pubmed: 34790815
Cancer Cell Int. 2022 Jun 28;22(1):220
pubmed: 35761336
Cancer. 2010 Apr 1;116(7):1674-80
pubmed: 20143430
BMC Cancer. 2013 Sep 24;13:436
pubmed: 24063854
Sci Transl Med. 2014 Feb 19;6(224):224ra24
pubmed: 24553385
Oncogene. 2014 Jan 23;33(4):514-24
pubmed: 23334332
Gastroenterology. 2022 May;162(6):1665-1674.e2
pubmed: 35065983
Int J Oncol. 2015 Jan;46(1):17-27
pubmed: 25338714
Int J Cancer. 2012 Aug 1;131(3):683-91
pubmed: 21913185
J Cancer. 2018 Sep 8;9(18):3417-3426
pubmed: 30271504
Cell Physiol Biochem. 2015;37(3):1002-9
pubmed: 26393913
J Gastrointest Oncol. 2015 Aug;6(4):358-74
pubmed: 26261723
Trends Mol Med. 2021 May;27(5):482-500
pubmed: 33500194
Sci Rep. 2020 Sep 16;10(1):14879
pubmed: 32938972
Cancer Immunol Res. 2021 Dec;9(12):1439-1450
pubmed: 34526323
Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):498-504
pubmed: 15701833
Cancer Biomark. 2016 Mar 11;16(4):537-43
pubmed: 27002756
Ann Oncol. 2019 Oct 1;30(10):1580-1590
pubmed: 31373349
Cancer Cell Int. 2022 Nov 3;22(1):334
pubmed: 36329447
Cancer Med. 2019 Sep;8(12):5638-5650
pubmed: 31389160
PLoS One. 2015 Jul 02;10(7):e0132223
pubmed: 26133769
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Int J Oncol. 2003 Feb;22(2):425-30
pubmed: 12527944
Nature. 2015 Jul 9;523(7559):177-82
pubmed: 26106858
Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):E1826-34
pubmed: 26976580
Clin Chim Acta. 2016 Jun 1;457:130-6
pubmed: 27079357
Nat Commun. 2018 Nov 29;9(1):5068
pubmed: 30498206
Transl Cancer Res. 2020 Feb;9(2):421-431
pubmed: 35117387
Asian Pac J Cancer Prev. 2015;16(15):6569-73
pubmed: 26434876
Int J Environ Res Public Health. 2022 Jan 15;19(2):
pubmed: 35055770
Cell Biol Toxicol. 2019 Aug;35(4):333-343
pubmed: 30771135
J Gastroenterol Hepatol. 2004 Feb;19(2):182-6
pubmed: 14731128
J Transl Med. 2020 Nov 7;18(1):420
pubmed: 33160365
Oncotarget. 2017 Jan 24;8(4):6085-6101
pubmed: 28030832
Proteomics Clin Appl. 2008 Jul;2(7-8):1047-57
pubmed: 21136905
Mol Cancer. 2010 Jul 27;9:198
pubmed: 20663213
Front Genet. 2022 Feb 24;13:816173
pubmed: 35281843
Trends Cancer. 2022 Mar;8(3):226-241
pubmed: 34952829
Nat Commun. 2020 Oct 19;11(1):5270
pubmed: 33077732
CMAJ. 2007 Aug 14;177(4):361-8
pubmed: 17698825
Proteomics. 2006 Jul;6(13):3871-9
pubmed: 16739137
Cancer Sci. 2019 Sep;110(9):2846-2855
pubmed: 31325200
Oncogene. 2003 Sep 11;22(39):8031-41
pubmed: 12970751
Cancer Cell. 2020 Apr 13;37(4):485-495
pubmed: 32289272
Pancreatology. 2020 Jan;20(1):51-59
pubmed: 31791885
Eur J Surg Oncol. 2007 Apr;33(3):266-70
pubmed: 17097848
Clin Epigenetics. 2019 Mar 4;11(1):38
pubmed: 30832724